Taking the question as asked, rather than the general version of it. Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third retelling.
I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
The narrow version of the question is how people are thinking about the trade-off between reversibility and privacy, because you cannot have both.
Not looking for reassurance. Looking for the part I have got wrong.
MikeFit_NJ said:Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…
Right, and the exception is worth naming rather than left implied, because the exception is where people get into trouble.
PeptideMeter — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsJessicaM_2024 said:I have used three payment routes and the only thing that changed with each was how much leverage I had when something went wrong.
Can confirm. Same sequence, different timescale. The detail I would add is minor and it is already implied above.
Adding the clinical framing, because it changes how the question reads. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.